Preoperative Oral Methadone for Patients Undergoing Cardiac Surgery: Reduction of Postoperative Pain
1 other identifier
interventional
21
1 country
1
Brief Summary
Oral medications like gabapentin and acetaminophen are commonly given to patients prior to surgery to provide balanced anaesthesia. Intravenous methadone has been shown to decrease postoperative pain as well as postoperative nausea and vomiting, which are known barriers to discharge. Oral methadone would be a convenient alternative to give as a preoperative medication with its bioavailability approaching 80%. No clinical trials to date have explored the utility of oral methadone as a preoperative analgesic to improve postoperative outcomes. Current literature shows preoperative IV methadone reduces opioid consumption in the perioperative period for cardiac surgeries; therefore, investigators hypothesize that preoperative oral methadone will also reduce postoperative pain and opioid consumption in patients undergoing sternotomy for cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 pain
Started Apr 2016
Typical duration for phase_2 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 6, 2016
CompletedFirst Posted
Study publicly available on registry
May 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJanuary 2, 2018
December 1, 2017
4 months
April 6, 2016
December 28, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Pain score (VRS)
Pain score as measured by 0-10 Verbal Rating Score (VRS)
24 hours
Secondary Outcomes (5)
Total Morphine Consumption (mg)
72 hours
Pain score (VRS)
Up to 72 hours postoperative
Time to extubation
up to 24 hours postoperative
Level of sedation
up to 72 hours postoperative
Incidence of opioid-related side effects
up to 72 hours postoperative
Study Arms (2)
Methadone
EXPERIMENTALMethadone 0.3 mg/kg (to a maximum of 30 mg) will be given to the patient preoperatively.
Placebo
PLACEBO COMPARATOREquivalent volume (5mL) of syrup will be given to the patient preoperatively.
Interventions
Eligibility Criteria
You may qualify if:
- presenting for elective first-time CABG cardiac surgery with anticipated extubation within 12 hours
You may not qualify if:
- \< 18 years of age
- preoperative renal failure requiring dialysis or serum creatinine greater than 176 µmol/L
- significant hepatic dysfunction (liver function tests more than twice the upper limit of normal)
- ejection fraction less than 30%
- corrected QT interval (QTc) on ECG \> 440ms for men and 450ms for women
- pulmonary disease necessitating home oxygen therapy
- preoperative requirement for inotropic agents or intra-aortic balloon pump to maintain hemodynamic stability
- emergency surgery
- allergy to methadone
- use of preoperative opioids or recent history of opioid abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saskatoon Health Region, 410 22nd Street East
Saskatoon, Saskatchewan, S7K 5T6, Canada
Related Publications (1)
Bolton TM, Chomicki SO, McKay WP, Pikaluk DR, Betcher JG, Tsang JC. Preoperative oral methadone for postoperative pain in patients undergoing cardiac surgery: A randomized double-blind placebo-controlled pilot. Can J Pain. 2019 Apr 9;3(1):49-57. doi: 10.1080/24740527.2019.1575695. eCollection 2019.
PMID: 35005393DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William PS McKay, MD FRCPC
Department of Anesthesiology, University of Saskatchewan
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD FRCPC
Study Record Dates
First Submitted
April 6, 2016
First Posted
May 17, 2016
Study Start
April 1, 2016
Primary Completion
August 1, 2016
Study Completion
December 1, 2017
Last Updated
January 2, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will share